Get the composition of our in-house portfolios

Portfolio Ref: EQ355LO2W
Performance in the last:
1D 0.0 %
1W 1.0 %
2W 5.9 %
1M 5.2 %
3M 0.8 %
6M 0.5 %
9M -6.2 %
1Y 3.5 %
Alpha
-3.3%
Beta
0.32
sharpe-R
0.23
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
1.69
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2025-02-04 07:50:17
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -13.4%
Max. DrawDown Benchmark -8.41%

This Long Only strategy aims to find promising assets to invest in for a maximum holding period of 2 Weeks in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 5.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
4
Difficulty Level
2

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Asset Class Action Weight PnL
NTRA Natera, Inc. Equity Buy 19.86% 0.16%
The percentage of cash held in the portfolio is: 80.14%
** The description of each asset is available Here

The latest 5 Compositions change

2025-02-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTRA Natera, Inc. Buy 19.89% 0.37%
The percentage of cash held in the portfolio is: 80.11%
New Assets Added
None
Assets Removed
Asset Action Perf %
GKOS Sell All 0.03%
Assets Rebalanced
None
2025-01-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
GKOS Glaukos Corporation Buy 18.79% 0.87%
NTRA Natera, Inc. Buy 19.8% 0%
The percentage of cash held in the portfolio is: 61.41%
New Assets Added
  • NTRA
Assets Removed
Asset Action Perf %
DNLI Sell All 8.81%
Assets Rebalanced
None
2025-01-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
DNLI Denali Therapeutics Inc. Buy 20.1% 8.03%
GKOS Glaukos Corporation Buy 18.94% 1.68%
The percentage of cash held in the portfolio is: 60.96%
New Assets Added
None
Assets Removed
Asset Action Perf %
AXSM Sell All 12.15%
INSM Sell All 11.11%
Assets Rebalanced
None
2025-01-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
AXSM Axsome Therapeutics, Inc. Buy 19.35% -1.94%
INSM Insmed Incorporated Buy 20.38% 3.29%
DNLI Denali Therapeutics Inc. Buy 19.95% 1.2%
GKOS Glaukos Corporation Buy 19.75% 0%
The percentage of cash held in the portfolio is: 20.56%
New Assets Added
None
Assets Removed
Asset Action Perf %
TNDM Sell All NA
Assets Rebalanced
None
2025-01-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 18.56% -5.9%
AXSM Axsome Therapeutics, Inc. Buy 19.35% -1.94%
INSM Insmed Incorporated Buy 20.38% 3.29%
DNLI Denali Therapeutics Inc. Buy 19.95% 1.2%
GKOS Glaukos Corporation Buy 19.75% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • GKOS
Assets Removed
None
Assets Rebalanced
None
2025-01-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 19.54% 0.47%
AXSM Axsome Therapeutics, Inc. Buy 19.44% -0.06%
INSM Insmed Incorporated Buy 20.16% 3.63%
DNLI Denali Therapeutics Inc. Buy 19.43% 0%
The percentage of cash held in the portfolio is: 21.43%
New Assets Added
  • DNLI
Assets Removed
None
Assets Rebalanced
None

Market Overview

Cookies Settings